We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » J&J Seeks Emergency Use Approval of Single Dose COVID-19 Vaccine
J&J Seeks Emergency Use Approval of Single Dose COVID-19 Vaccine
Johnson & Johnson (J&J) filed yesterday for FDA Emergency Use Authorization (EUA) of its single-dose COVID-19 vaccine — which if granted will help ease vaccine supply shortages and significantly ramp up the pace of inoculations in the U.S.